A2 Refereed review article in a scientific journal
Emerging histopathologic markers in early-stage oral tongue cancer: A systematic review and meta-analysis
Authors: Elseragy Amr, Bello Ibrahim O., Wahab Awais, Coletta Ricardo D., Mäkitie Antti A., Leivo Ilmo, Almangush Alhadi, Salo Tuula
Publisher: WILEY
Publication year: 2022
Journal: Head and Neck
Journal acronym: HEAD NECK-J SCI SPEC
Volume: 44
Issue: 6
First page : 1481
Last page: 1491
Number of pages: 11
ISSN: 1043-3074
eISSN: 1097-0347
DOI: https://doi.org/10.1002/hed.27022
Web address : https://onlinelibrary.wiley.com/doi/10.1002/hed.27022
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/175203739
Although there are many histopathologic prognosticators, grading of early oral tongue squamous cell carcinoma (OTSCC) is still based on morphological cell differentiation which has low prognostic value. Here we summarize the emerging histopathological markers showing powerful prognostic value, but are not included in pathology reports. Using PubMed, Scopus, Ovid Medline, and Web of Science databases, a systematic literature search was preformed to identify early OTSCC studies that investigated the prognostic significance of hematoxylin-eosin-based histopathologic markers. Our meta-analysis showed that tumor budding was associated with overall survival (hazard ratio [HR] 2.32; 95% CI 1.40-3.84; p < 0.01) and disease-specific survival (DSS) (1.89; 95% CI 1.13-3.15; p = 0.02). Worst pattern of invasion was associated with disease-free survival (DFS) (1.95; 95% CI 1.04-3.64; p = 0.04). Tumor-stroma ratio was also associated with DFS (1.75, 95% CI 1.24-2.48; p < 0.01) and DSS (1.69; 95% CI 1.19-2.42; p < 0.01). Tumor budding, worst pattern of invasion, and tumor-stroma ratio have a promising prognostic value in early OTSCC. The evaluation and reporting of these markers is cost-effective and can be incorporated in daily practice.
Downloadable publication This is an electronic reprint of the original article. |